Explore

Rapid Read Rapid Read
SignalPGx Launches White-Label Pharmacogenomics Platform for CLIA Laboratories

SignalPGx Launches White-Label Pharmacogenomics Platform for CLIA Laboratories

SignalPGx LLC has announced the launch of its new global pharmacogenomics reporting and medication intelligence platform. This platform is designed for laboratories, hospital systems, provider networks, clinics, pharmacy partners, and other healthcare enterprises. The core function of SignalPGx is to transform complex genotype data into clear, evidence-backed medication guidance. It offers white-label PGx reports, physician-reviewed workflows, and SignalAI-assisted interpretation. The platform also features EHR-ready integrations, medication simulation, living reanalysis, and a patient-accessible Living Patient Passport. According to Tarek Younis, Founder and CEO of SignalPGx, the goal is to provide 'living medication intelligence' that supports clinical review, EHR integration, patient access, and long-term medication safety. The platform currently supports over 50 pharmacogenes and approximately 950 medications with clinical PGx guidance, incorporating evidence from sources like CPIC, DPWG, FDA drug labe...
Rapid Read Rapid Read
OpenAI Foundation Pledges $100 Million to Boost U.S. Hepatitis C Cure Rates with AI

OpenAI Foundation Pledges $100 Million to Boost U.S. Hepatitis C Cure Rates with AI

The OpenAI Foundation has committed $100 million to a new public health initiative in the United States, aiming to leverage artificial intelligence (AI) to improve hepatitis C cure rates. This initiative, named Breakthroughs to Follow-Through (B2F), is a partnership with the Common Health Coalition. The program's initial focus is on hepatitis C, with plans to expand to other areas like HIV prevention and treatable cancers if successful. Despite oral medicines being able to cure over 95% of hepatitis C patients in a short period, approximately two-thirds of those with the condition in the U.S. remain untreated, leading to around 40 preventable deaths daily. The B2F program will deploy AI-enabled tools to help states and local jurisdictions identify and re-engage patients who have fallen out of the treatment pathway. Initial funding will support efforts in Alabama, Illinois, Louisiana, and Massachusetts, with additional jurisdictions expected to join within six months. EqualCure, a national hepatitis C treat...
Rapid Read Rapid Read
Pharmacogenomics Utilizes Genetic Makeup to Optimize Medication Response and Reduce Side Effects

Pharmacogenomics Utilizes Genetic Makeup to Optimize Medication Response and Reduce Side Effects

Pharmacogenomics, also known as drug pharmacogenomics or pharmacogenetic testing, is a field that analyzes an individual's genetic makeup to understand how it influences their response to medications. This genetic testing identifies variations in genes that affect drug metabolism, effectiveness, and the potential for side effects. The information derived from these tests helps healthcare providers select the most appropriate medication and dosage, tailoring treatment to an individual's unique genetic profile. This personalized approach is frequently applied in managing various conditions, including cancer, cardiovascular diseases, depression, and epilepsy. The goal is to optimize drug therapy, reduce adverse drug reactions, improve treatment outcomes, and avoid the trial-and-error prescribing methods that can be time-consuming and costly. Individuals starting new medications, those who have experienced adverse reactions or a lack of response to standard treatments, and people with chronic conditions requir...
Rapid Read Rapid Read
Mayo Clinic Advises on Irregular Blood Pressure Patterns and Consulting Doctors

Mayo Clinic Advises on Irregular Blood Pressure Patterns and Consulting Doctors

The Mayo Clinic provides guidance on blood pressure fluctuations, emphasizing that while daily variations are normal, certain irregular patterns warrant medical consultation. According to the Mayo Clinic, concerning patterns include consistently high blood pressure during the night (when it should be at its lowest), elevated blood pressure early in the morning (when it should be gradually rising), or a nocturnal blood pressure drop of less than 10%. These indicators suggest potential underlying health issues that require a doctor's attention. Additionally, the Mayo Clinic highlights labile hypertension, characterized by sudden, brief blood pressure spikes without a clear trigger, as another pattern that necessitates medical evaluation. These recommendations aim to help individuals identify when normal physiological fluctuations cross into potentially problematic territory, guiding them to seek professional medical advice for proper diagnosis and management.
Trendline Trendline
Biopharma Industry Navigates Multipolar Landscape with Rise of Chinese Biotech and Evolving Global Markets

Biopharma Industry Navigates Multipolar Landscape with Rise of Chinese Biotech and Evolving Global Markets

Biopharma Industry Navigates Multipolar Landscape with Rise of Chinese Biotech and Evolving Global Markets
Trendline Trendline
Axios Partners with OpenAI to Automate Local Journalism, Raising Ethical Concerns

Axios Partners with OpenAI to Automate Local Journalism, Raising Ethical Concerns

Axios Partners with OpenAI to Automate Local Journalism, Raising Ethical Concerns
Trendline Trendline
Health Gorilla Appoints Ryan Smith as Chief Technology Officer to Bolster National Health Data Exchange

Health Gorilla Appoints Ryan Smith as Chief Technology Officer to Bolster National Health Data Exchange

Health Gorilla Appoints Ryan Smith as Chief Technology Officer to Bolster National Health Data Exchange
Trendline Trendline
Wearable Technology and Biosensors Increasingly Integrated into Rehabilitation Services

Wearable Technology and Biosensors Increasingly Integrated into Rehabilitation Services

Wearable Technology and Biosensors Increasingly Integrated into Rehabilitation Services
Trendline Trendline
Personalized Nutrition Gains Traction with Advanced Technologies for Health and Fitness

Personalized Nutrition Gains Traction with Advanced Technologies for Health and Fitness

Personalized Nutrition Gains Traction with Advanced Technologies for Health and Fitness
Rapid Read Rapid Read
Abridge Expands AI Clinical Decision Support to All Clinicians Across 300+ Health Systems

Abridge Expands AI Clinical Decision Support to All Clinicians Across 300+ Health Systems

Abridge, an artificial intelligence company, is expanding its AI-based clinical decision support (CDS) solution to all clinicians within its network of over 300 partner health systems. This move is part of Abridge's broader strategy to evolve from AI documentation tools to an enterprise AI assistant for healthcare professionals. The CDS solution, which integrates with existing electronic health record (EHR) systems, provides context-aware, evidence-based answers at the point of care. According to Shiv Rao, M.D., CEO and co-founder of Abridge, adoption of this decision support has significantly outpaced previous offerings, with monthly active users growing to over half of eligible Abridge clinicians and queries per clinician tripling in the last two months. The technology supports over 100 million clinical conversations annually and has content integrations with major medical literature sources like The New England Journal of Medicine and Wolters Kluwer's UpToDate.
Trendline Trendline
OmniAb Raises 2026 Financial Guidance Following Increased Technology Licensing Activity

OmniAb Raises 2026 Financial Guidance Following Increased Technology Licensing Activity

OmniAb Raises 2026 Financial Guidance Following Increased Technology Licensing Activity
USA Today USA Today
Bruce Willis makes rare appearance at daughter Tallulah's wedding

Bruce Willis makes rare appearance at daughter Tallulah's wedding

Bruce Willis attended his daughter Tallulah Willis' wedding to Justin Acee amid the "Die Hard" star's ongoing battle with frontotemporal dementia.